{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T17:14:57Z","timestamp":1772126097721,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,26]]},"DOI":"10.7759\/cureus.104296","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T16:04:03Z","timestamp":1772121843000},"source":"Crossref","is-referenced-by-count":0,"title":["An Unusual Pattern of Hepatic Involvement in Plasma Cell Leukemia"],"prefix":"10.7759","author":[{"given":"Matt Andrew M","family":"Paz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amira","family":"Hamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Ehster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robben","family":"Schat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Supriya","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismail","family":"Elbaz Younes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byoung Uk","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Sulla produzione cellulare nell\u2019infiammazione ed in altri processi analoghi, specialmente in ci\u00f2 che si riferisce alle plasmacellule","volume":"1","author":"Foa P","year":"1904","unstructured":"Foa P. Sulla produzione cellulare nell\u2019infiammazione ed in altri processi analoghi, specialmente in ci\u00f2 che si riferisce alle plasmacellule. Folia Haematol. 1904, 1:166-7.","journal-title":"Folia Haematol"},{"key":"ref2","article-title":"Myeloma and leucaemia lymphatica plasmocellularis","volume":"19","author":"Gluzi\u0144ski WA","year":"1907","unstructured":"Gluzi\u0144ski WA, Reichenstein M. Myeloma and leucaemia lymphatica plasmocellularis. Wien Klin Wochenschr. 1907, 19:336-9.","journal-title":"Wien Klin Wochenschr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.133.5.813","article-title":"Plasma cell leukemia. Report on 17 cases","volume":"133","author":"Kyle RA","year":"1974","unstructured":"Kyle RA, Maldonado JE, Bayrd ED. Plasma cell leukemia. Report on 17 cases. Arch Intern Med. 1974, 133:813-8. 10.1001\/archinte.133.5.813","journal-title":"Arch Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group","volume":"121","author":"The International Myeloma Working Group","year":"2003","unstructured":"The International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003, 121:749-57. 10.1046\/j.1365-2141.2003.04355.x","journal-title":"Br J Haematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00587-0","article-title":"Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage","volume":"11","author":"Fern\u00e1ndez de Larrea C","year":"2021","unstructured":"Fern\u00e1ndez de Larrea C, Kyle R, Rosi\u00f1ol L, et al.. Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage. Blood Cancer J. 2021, 11:192. 10.1038\/s41408-021-00587-0","journal-title":"Blood Cancer J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(05)70125-8","article-title":"Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia","volume":"13","author":"Blad\u00e9 J","year":"1999","unstructured":"Blad\u00e9 J, Kyle RA. Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia. Hematol Oncol Clin North Am. 1999, 13:1259-72. 10.1016\/S0889-8588(05)70125-8","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.336","article-title":"Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group","volume":"27","author":"Fern\u00e1ndez de Larrea C","year":"2013","unstructured":"Fern\u00e1ndez de Larrea C, Kyle RA, Durie BG, et al.. Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group. Leukemia. 2013, 27:780-91. 10.1038\/leu.2012.336","journal-title":"Leukemia"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90942-9","article-title":"Plasma cell leukemia: an evaluation of response to therapy","volume":"83","author":"Noel P","year":"1987","unstructured":"Noel P, Kyle RA. Plasma cell leukemia: an evaluation of response to therapy. Am J Med. 1987, 83:1062-8. 10.1016\/0002-9343(87)90942-9","journal-title":"Am J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.107","article-title":"Primary plasma cell leukemia: clinical and laboratory presentation, gene-expression profiling and clinical outcome with Total Therapy protocols","volume":"26","author":"Usmani SZ","year":"2012","unstructured":"Usmani SZ, Nair B, Qu P, et al.. Primary plasma cell leukemia: clinical and laboratory presentation, gene-expression profiling and clinical outcome with Total Therapy protocols. Leukemia. 2012, 26:2398-405. 10.1038\/leu.2012.107","journal-title":"Leukemia"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-05-408682","article-title":"How I treat plasma cell leukemia","volume":"120","author":"van de Donk NW","year":"2012","unstructured":"van de Donk NW, Lokhorst HM, Anderson KC, Richardson PG. How I treat plasma cell leukemia. Blood. 2012, 120:2376-89. 10.1182\/blood-2012-05-408682","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00135-5","article-title":"Multiple myeloma","volume":"397","author":"van de Donk NWCJ","year":"2021","unstructured":"van de Donk NWCJ, Pawlyn C, Yong KL. Multiple myeloma. Lancet. 2021, 397:410-27. 10.1016\/S0140-6736(21)00135-5","journal-title":"Lancet"},{"key":"ref12","article-title":"Plasma cell neoplasms","author":"McKenna RW","year":"2017","unstructured":"McKenna RW, Kyle RA, Kuehl WM, Harris NL, Coupland RW, Fend F. Plasma cell neoplasms. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Swerdlow SH, Campo E, Harris NL, et al. (ed): International Agency for Research on Cancer,  Lyon, France; 2017. 241-58."},{"key":"ref13","article-title":"Plasma cell myeloma\/multiple myeloma","author":"Kumar S","year":"2022","unstructured":"Kumar S, Baughn LB, Cowan AJ, et al.. Plasma cell myeloma\/multiple myeloma. Haematolymphoid Tumours. Chng WJ (ed): International Agency for Research on Cancer, Lyon, France; 2022. 625-33."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo E","year":"2022","unstructured":"Campo E, Jaffe ES, Cook JR, et al.. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood. 2022, 140:1229-53. 10.1182\/blood.2022015851","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-022-00643-3","article-title":"Extramedullary disease in multiple myeloma: a systematic literature review","volume":"12","author":"Blad\u00e9 J","year":"2022","unstructured":"Blad\u00e9 J, Beksac M, Caers J, et al.. Extramedullary disease in multiple myeloma: a systematic literature review. Blood Cancer J. 2022, 12:45. 10.1038\/s41408-022-00643-3","journal-title":"Blood Cancer J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V52.4.839.839","article-title":"Plasma cell leukemia (PCL): A report on 15 patients","volume":"52","author":"Woodruff RK","year":"1978","unstructured":"Woodruff RK, Malpas JS, Paxton AM, Lister TA. Plasma cell leukemia (PCL): A report on 15 patients. Blood. 1978, 52:839-45. 10.1182\/blood.V52.4.839.839","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Palumbo A","year":"2011","unstructured":"Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011, 364:1046-60. 10.1056\/NEJMra1011442","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2025.01.022","article-title":"European Myeloma Network Group review and consensus statement on primary plasma cell leukemia","volume":"36","author":"Musto P","year":"2025","unstructured":"Musto P, Engelhardt M, van de Donk NW, et al.. European Myeloma Network Group review and consensus statement on primary plasma cell leukemia. Ann Oncol. 2025, 36:361-74. 10.1016\/j.annonc.2025.01.022","journal-title":"Ann Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/his.14778","article-title":"Gastrointestinal, hepatic, and pancreatobiliary involvement by plasma cell neoplasms: clinicopathologic correlations in a retrospective cohort of 116 cases","volume":"81","author":"Kelley JT","year":"2022","unstructured":"Kelley JT, Fuller LD, Lai KK, et al.. Gastrointestinal, hepatic, and pancreatobiliary involvement by plasma cell neoplasms: clinicopathologic correlations in a retrospective cohort of 116 cases. Histopathology. 2022, 81:742-57. 10.1111\/his.14778","journal-title":"Histopathology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.15.2038","article-title":"Hepatic failure caused by plasma cell infiltration in multiple myeloma","volume":"15","author":"Rahhal FE","year":"2009","unstructured":"Rahhal FE, Schade RR, Nayak A, Coleman TA. Hepatic failure caused by plasma cell infiltration in multiple myeloma. World J Gastroenterol. 2009, 15:2038-40. 10.3748\/wjg.15.2038","journal-title":"World J Gastroenterol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7954816","article-title":"Multiple liver nodules mimicking metastatic disease as initial presentation of multiple myeloma","volume":"8","author":"Tiu AC","year":"2018","unstructured":"Tiu AC, Potdar R, Arguello-Gerra V, Morginstin M. Multiple liver nodules mimicking metastatic disease as initial presentation of multiple myeloma. Case Rep Hematol. 2018, 8:6. 10.1155\/2018\/7954816","journal-title":"Case Rep Hematol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5738319","article-title":"A case with hepatic involvement mimicking metastatic disease in multiple myeloma","volume":"5","author":"Erciyestepe M","year":"2020","unstructured":"Erciyestepe M, Tiryaki TO, Y\u00f6nal Hindilerden \u0130, Ye\u011fen G, Nal\u00e7ac\u0131 M. A case with hepatic involvement mimicking metastatic disease in multiple myeloma. Case Rep Hematol. 2020, 5:9. 10.1155\/2020\/5738319","journal-title":"Case Rep Hematol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.941437","article-title":"Molecular impact of the tumor microenvironment on multiple myeloma dissemination and extramedullary disease","volume":"12","author":"Forster S","year":"2022","unstructured":"Forster S, Radpour R. Molecular impact of the tumor microenvironment on multiple myeloma dissemination and extramedullary disease. Front Oncol. 2022, 12:7. 10.3389\/fonc.2022.941437","journal-title":"Front Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/467338-an-unusual-pattern-of-hepatic-involvement-in-plasma-cell-leukemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T16:04:04Z","timestamp":1772121844000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/467338-an-unusual-pattern-of-hepatic-involvement-in-plasma-cell-leukemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.104296","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,26]]}}}